Concept Life Sciences is a Malvern Panalytical brand, following our integration in April, 2021. We are a contract research and manufacturing organization, home to more than 250 employees working from five laboratories across the United Kingdom.
We have grown and specialized through a combination of organic growth and targeted acquisition - most recently Aquila Biomedical in 2018. But we originally formed in 2014, following the merger of Scientific Analysis Laboratories (SAL), Agenda1 Analytical Services, Peakdale Molecular, CXR Biosciences and Resource & Environmental Consultants (REC).
We offer a comprehensive range of discovery and development services and analytical solutions across the pharmaceutical, biotechnology and agrochemical sectors. We cover all activities from target to clinic, including discovery chemistry, biology, DMPK, bioanalysis, toxicology and GMP manufacturing.